Barclay Phillips Net Worth & Insider Trades
Barclay Phillips - SVP, Novavax Inc
What is Barclay Phillips's Net Worth?
The current estimated net worth of Novavax Inc's SVP, Barclay Phillips, is estimated to be about $8.1M . Barclay Phillips owns about 38,669 units of Novavax Inc common stock. In the last 4 years at Novavax Inc, Barclay Phillips has sold an estimated value of $395.55K worth.
What is Barclay Phillips's Past Insider Trading?
Barclay Phillips's largest purchase order was 50,000 units , worth over $95K on July 3, 2013. Barclay Phillips's largest sale order was 28,656 units , worth over $374.32K on August 21, 2015. In total, Barclay Phillips has made about 16 transactions over 4 years of their time at Novavax Inc. Barclay Phillips usually trades in August, with the busiest year in 2016, 2014 and 2015. The most recent transaction was a purchase order of 2,057 units , worth over $1.83K on August 1, 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BARCLAY PHILLIPS
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Barclay Phillips's' Mailing Address?
- Mailing address is C/o Cancer Vax Corp 2110 Rutherford Road Carlsbad CA 92008 CA
Novavax Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|
| Stanley C. Erck Stanley C. Erck | 2020 | $657,181 | $48,086,018 | $44,115,244 | $48,086,018 | $11,400 | $48,086,018 |
| Stanley C. Erck Stanley C. Erck | 2019 | $642,720 | $2,438,562 | $986,660 | $2,438,562 | $11,200 | $2,438,562 |
| Stanley C. Erck Stanley C. Erck | 2018 | $638,040 | $4,158,398 | $3,509,358 | $4,158,398 | $11,000 | $4,158,398 |
| Gregory F. Covino | 2020 | $55,000 | $1,417,774 | $659,967 | $1,417,774 | $8,032 | $1,417,774 |
| Gregory F. Covino | 2019 | $― | $― | $― | $― | $― | $― |
| Gregory F. Covino | 2018 | $― | $― | $― | $― | $― | $― |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2020 | $483,443 | $24,923,376 | $22,859,741 | $24,923,376 | $11,400 | $24,923,376 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2019 | $470,453 | $1,875,198 | $819,421 | $1,875,198 | $11,200 | $1,875,198 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2018 | $460,125 | $1,681,456 | $1,131,189 | $1,681,456 | $11,000 | $1,681,456 |
| John J. Trizzino John J. Trizzino | 2020 | $415,892 | $21,327,954 | $19,819,717 | $21,327,954 | $11,400 | $21,327,954 |
| John J. Trizzino John J. Trizzino | 2019 | $390,701 | $1,465,602 | $584,103 | $1,465,602 | $9,546 | $1,465,602 |
| John J. Trizzino John J. Trizzino | 2018 | $378,078 | $1,329,776 | $890,700 | $1,329,776 | $7,500 | $1,329,776 |
| John A. Herrmann III John A. Herrmann III | 2020 | $402,842 | $20,606,814 | $18,924,907 | $20,606,814 | $11,400 | $20,606,814 |
| John A. Herrmann III John A. Herrmann III | 2019 | $378,591 | $1,353,416 | $488,397 | $1,353,416 | $11,200 | $1,353,416 |
| John A. Herrmann III John A. Herrmann III | 2018 | $362,695 | $1,137,576 | $712,560 | $1,137,576 | $11,000 | $1,137,576 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm
What are Novavax Inc's Past Insider Trades?
Novavax Inc's most recent insider trade came on March 14, 2023 by Gregory Glenn who sold 2,432 units worth $15.86K . In the last 20 years, insiders at Novavax Inc have sold an estimated value of $287.12M and bought an estimated value of $38.46M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President, John A. Herrmann Iii Attorney-In-Fact, EVP, and John A. Herrmann III, EVP .
NOVAVAX INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||